Pathophysiological Evidence Driven Management of GERD in Neonatal ICU Infants: Randomized Controlled Trial
Pathophysiological Evidence Driven Management of GERD in Neonatal ICU Infants: Randomized Controlled Trial
批准号:
10717324
负责人:
Sudarshan R Jadcherla
金额:
$66.36万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2028-08-31
关键词:
AcidsAdverse effectsAgeAlgorithmsBenchmarkingBiological MarkersCaringCategoriesCerealsCharacteristicsChildhoodChronologyClinic VisitsClinicalClinical TrialsCoughingDataDiagnosisDiagnosticDiagnostic testsDistalEatingEconomic BurdenEconomicsEffectivenessEnteral FeedingEquilibriumEquipoiseEsophagusEvaluationEventEvidence based practiceEvidence based treatmentFailureFeeding MethodsFeedsFutureGastroesophageal reflux diseaseGoalsGrowthHealthHospitalizationHourInfantIntakeInterventionKnowledgeLength of StayMeasurementMissionModificationNational Institute of Diabetes and Digestive and Kidney DiseasesNeonatalNeonatal Intensive Care UnitsNeurologicNutrientOralOutcomeParentsPathologicPeripheralPharmaceutical PreparationsPhysiologicalPopulationPregnancyPrevalenceProbabilityProton Pump InhibitorsProviderPublic HealthQuality of lifeRandomizedRandomized, Controlled TrialsRelative RisksResearchResearch PersonnelRiceSafetySeveritiesSeverity of illnessStratificationSymptomsTestingTherapeuticTherapeutic EffectTimeTreatment EfficacyTubeUnited States National Institutes of HealthVariantVomitingWorkarmassociated symptomclinical efficacycomparative efficacycostdecision making algorithmdesigndiagnostic algorithmdiagnostic criteriadisease diagnosiseffective therapyefficacy testingelectric impedanceevidence basefeedingfollow-uphigh riskhigh risk infanthospital readmissionimprovedindexingnovelnovel diagnosticsnutritionprimary endpointprimary outcomeprogramsresponsesecondary outcomeskillssocioeconomicsstemsuccesstreatment grouptreatment responseunnecessary treatment
中文摘要
项目总结/摘要
胃食管反流病(GERD)的胃镜诊断、经验性治疗、
高危住院婴儿的实践差异仍然很高。之前的临床试验数据缺乏生理学-
客观的诊断证据和治疗。胃食管反流病的诊断标准往往不充分,
GERD治疗的相对风险、益处和适应症尚不清楚。因此,知识差距依然存在,
GERD诊断可能会花费额外的7万美元和每个婴儿30天的住院治疗。客观,有效,
迫切需要循证疗法。几乎所有新生儿重症监护室(NICU)的婴儿
有症状,24小时pH阻抗(pH-Imp)测试可以客观诊断和检测
病理生理学GERD的机制。因此,本研究的总体目标是进行单中心
随机对照试验(RCT),以检验中心假设,即普通疗法的效果[自然
成熟、酸抑制-质子泵抑制剂(PPI)或使用添加的大米(AR)配方的增稠饲料]是
在6个月以下校正成熟年龄的高风险婴儿中,pH-Imp定义的GERD标准明显。
其基本原理是完善新的诊断标准,并严格调查随机治疗的影响
实现创造有效、简化、循证和可扩展治疗的长期目标
算法
我们将在以下具体目标中检验这一假设:目标1:进行随机对照试验,
干预措施对主要临床终点(经口喂养改善和缺乏
麻烦的症状),以测试AR上级自然成熟和PPI的工作假设。目标二:
评价pH-影响特征并测试以下工作假设:
a)分配的治疗,和B)临床成功和失败。该项目挑战了目前的经验方法,
通过使用pH-Imp指标的新组合和
随机分配和目标分层(GERD严重程度和喂养技能),以确定真正的
临床和机制特征的治疗效果。预期结果将确定诊断
用于确定GERD和有效治疗方法的算法。此外,拟议的研究是
意义重大,因为获得的知识将提供诊断基础、框架和科学,
未来研究的经济学原理,以进一步完善儿科年龄范围内的治疗。我们预计
制定GERD预防和治疗策略的新基准,这将对
通过改善消化系统健康、全面营养和生长,提高婴儿和父母的生活质量,
NIH的使命。
英文摘要
PROJECT SUMMARY/ABSTRACT
The prevalence of symptom-based diagnosis of gastroesophageal reflux disease (GERD), its empiric treatment,
and practice variation in high-risk hospitalized infants remain high. Prior clinical trials data lack physiological-
based, objective diagnostic evidence and treatment. GERD is frequently diagnosed by inadequate criteria, and
the relative risks, benefits, and indications of GERD therapies are unclear. Thus, gaps in knowledge persist, and
a GERD diagnosis can cost an extra $70k and 30 days of hospitalization per infant. Objective, effective,
evidence-based therapies are critically needed. As nearly all infants in the neonatal intensive care unit (NICU)
are symptomatic, twenty-four-hour pH-Impedance (pH-Imp) testing can diagnose objectively and detect
mechanisms of pathophysiologic GERD. Therefore, this study’s overall objective is to conduct a single-center
randomized control trial (RCT) to test the central hypothesis that the effects of common therapies [natural
maturation, acid suppression-proton pump inhibitor (PPI), or thickened feeds using added rice (AR) formula] are
distinct in high-risk infants, under six months corrected maturational age with pH-Imp defined criteria for GERD.
The rationale is to refine novel diagnostic criteria and rigorously investigate the impact of randomized therapies
to achieve the long-term goal of creating effective, simplified, evidence-based, and scalable treatment
algorithms.
We will test this hypothesis in the following Specific Aims: Aim 1: Conduct the RCT to evaluate and compare the
efficacy and safety of interventions on the primary clinical endpoint (oral feeding improvement and absence of
troublesome symptoms) to test the working hypothesis that AR is superior to natural maturation and PPI. Aim 2:
Evaluate pH-Imp characteristics and test the working hypotheses that pH-Imp mechanisms are distinct between
a) assigned therapies, and b) clinical success and failure. This project challenges current empiric approaches to
diagnosing and managing GERD in NICU infants by using both a novel combination of pH-Imp metrics and
randomized allocations with targeted stratification (GERD severity and feeding skills) to determine true
therapeutic effects on clinical and mechanistic characteristics. The anticipated outcomes will identify diagnostic
algorithms for determining GERD and effective treatment approaches. In addition, the proposed research is
significant because the knowledge gained will provide the diagnostic basis, framework, and scientific and
economic rationale for future studies to further refine therapies across the pediatric age spectrum. We expect
new benchmarks to develop preventative and therapeutic strategies for GERD, which will positively impact the
quality of life for infants and parents by improving digestive health, overall nutrition, and growth, all relevant to
the mission of NIH (NIDDK).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aerodigestive Pathophysiology-Driven Mechanisms of Infant Feeding Difficulties
-
批准号:10430145
-
项目类别:
-
资助金额:$51.1万
-
财政年份:2020
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Aerodigestive Pathophysiology-Driven Mechanisms of Infant Feeding Difficulties
-
批准号:10203954
-
项目类别:
-
资助金额:$54.05万
-
财政年份:2020
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Aerodigestive Pathophysiology-Driven Mechanisms of Infant Feeding Difficulties
-
批准号:10654585
-
项目类别:
-
资助金额:$51.1万
-
财政年份:2020
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Neonatal Esophagus and Airway Interaction in Health and Disease
-
批准号:8742109
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2007
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7393790
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7222731
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:8456057
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7772021
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7608666
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7809655
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:8289148
-
项目类别:
-
资助金额:$46.66万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
Pathophysiology of Aerodigestive Reflexes in Infants
-
批准号:7103299
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2006
-
负责人:Sudarshan R Jadcherla
-
依托单位:
ESOPHAGEAL MOTILITY AND AIRWAY DEFENSES AMONG INFANTS
-
批准号:6684707
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2002
-
负责人:Sudarshan R Jadcherla
-
依托单位:
ESOPHAGEAL MOTILITY AND AIRWAY DEFENSES AMONG INFANTS
-
批准号:6623157
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2002
-
负责人:Sudarshan R Jadcherla
-
依托单位:
ESOPHAGEAL MOTILITY AND AIRWAY DEFENSES AMONG INFANTS
-
批准号:6463591
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2002
-
负责人:Sudarshan R Jadcherla
-
依托单位:
海外基金